Advanced Biomed (ADVB) Capital Expenditures (2024 - 2026)

Advanced Biomed has disclosed Capital Expenditures across 3 years of filings, most recently posting $1264.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $1264.0, down 42.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $36090.0 (down 44.27% YoY), and the FY2025 annual result was $31650.0, down 57.29% from the prior year.
• Capital Expenditures came in at $1264.0 for Q1 2026 at Advanced Biomed, down from $12906.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $53256.0 in Q2 2024 to a low of -$26699.0 in Q1 2024.
• The 3-year median for Capital Expenditures is $2215.0 (2025), against an average of $8238.7.
• Peak annual rise in Capital Expenditures reached 220.71% in 2025, while the deepest fall reached 91.14% in 2025.
• Advanced Biomed's Capital Expenditures stood at -$10692.0 in 2024, then soared by 220.71% to $12906.0 in 2025, then tumbled by 90.21% to $1264.0 in 2026.
• The last three Capital Expenditures figures came in at $1264.0 (Q1 2026), $12906.0 (Q4 2025), and $1771.0 (Q3 2025), per Business Quant data.